The United States recorded more than 15,000 deaths from Covid-19 and over 1.2 million new cases for the week ended Dec. 27, though those numbers may be artificially low due to reporting gaps over the Christmas holiday.

The U.S. FDA gave Sanofi SA’s dengue vaccine Dengvaxia a very narrow approval as the company continues to suffer from evidence that its vaccine can cause severe infections in some people.

New York state sued Purdue Pharma LP, accusing the OxyContin maker of widespread fraud and deception in the marketing of opioids, and contributing to a nationwide epidemic.

The U.S. FDA expects a shortage of intravenous saline fluids for hospitals due to damage to key manufacturing facilities in Puerto Rico to improve over the coming weeks and months.

In terms of acquisitions, the company is looking to expand its immunology pipeline as well as oncology.

The U.S. House of Representatives approved legislation to continue a federal insurance program for millions of lower-income children and pregnant women, but with an ongoing funding battle it could be weeks before the program gets more money.

U.S. hospital products maker Baxter International Inc. forecast a nearly $70 million hit to its fourth-quarter 2017 revenue, due to manufacturing disruptions arising from Hurricane Maria.

The head of the U.S. Food and Drug Administration said the agency was working with several pharmaceutical and medical device companies in Puerto Rico to prevent shortages of medical products in the United States as it joins a massive effort to help rebuild the island that was ravaged by Hurricane Maria.

Adult women in Puerto Rico were significantly more likely to develop Zika than men, researchers said, raising new questions about the potential role of sexual transmission of the virus from males to females.

Japanese drugmaker Takeda Pharmaceutical Co. said it is developing a vaccine to prevent the Zika virus, which has been linked to severe birth defects, and has secured funding from a U.S. government agency.